ear-patient testing to guide COPD MaintenancE Treatment in primary care (COMET): observational study to determine variability and accuracy of inflammatory biomarkers in stable state

niversity of Oxford0 个研究点目标入组 96 人开始时间: 2017年1月31日最近更新: 2020年4月27日

试验速览

暂无简介。

•1. Participant is willing and able to give informed consent for participation in the study
•2. Male or Female, aged 40 years or above
•3. Have a diagnosis of COPD meeting spirometric criteria for diagnosis of COPD (FEV1/FVC ratio <0.7) as recorded in their primary care records

•1. Any previous diagnosis of bronchiectasis, cystic fibrosis, interstitial lung disease, lung cancer, alpha-1 anti-trypsin deficiency or other chronic respiratory disease not related to COPD or asthma
•2. Co-existent active diagnosis of asthma (reviewed in the last 2 years)
•3. Currently prescribed an ICS, or had a prescription for ICS in the last 2 years
•4. Regularly takes oral steroids, or has been regularly taking oral steroids in the last 2 years. Regular use of oral steroids will in general be defined as a longer than 2 week course, although discrete short courses with tapering are acceptable for inclusion.
•5. Prior inclusion in a clinical trial of an investigational medicinal product for airways disease in the last 90 days or which may involve administration of oral or inhaled steroid treatment

发起方